Skip to content
Rare Medication

Medicine profile

Carboplatin

Platinum chemotherapy used in multiple infusion regimens managed by oncology teams.

In shortageFDA drug shortage database - checked 20 Sept 2026Shortage page

What this medicine is commonly used for

Frequently requested during oncology drug shortage monitoring and hospital allocation planning.

Informational only. Treatment decisions belong to qualified clinicians and to local labeling.

Shortage and sourcing context

Carboplatin has appeared on shortage lists in several regions during manufacturing disruptions.

How it is presented

Examples of presentations referenced for this medicine. Actual market presentations vary by country and registration, so check the pack in front of you.

  • Infusion

Strength examples 10 mg/mL (example)

Who typically asks us about this medicine

  • Patients and families who cannot fill a prescription locally
  • Hospital pharmacies managing formulary access during a shortage
  • Clinics with defined treatment pathways and continuity of care
  • Procurement teams coordinating licensed cross-border sourcing

Frequently asked questions

Full reference text(expand)

Platinum chemotherapy used in multiple infusion regimens managed by oncology teams.

What this medicine is commonly associated with

Frequently requested during oncology drug shortage monitoring and hospital allocation planning.

Shortage and sourcing context

Carboplatin has appeared on shortage lists in several regions during manufacturing disruptions.

Procurement readers and documentation

Teams may attach formulary references, expected delivery windows, and importer details when permitted. This does not change clinical responsibilities.

Presentation examples

Dosage forms referenced on this page may include: Infusion. Strength examples may include: 10 mg/mL (example). Actual market presentations vary by region and registration.

Important: This page is informational and not a substitute for professional medical advice, local labeling, or institutional protocols.